Needham, MA, United States of America

Marc David Friedman

This inventor holds 43 USPTO granted patents and 22 published patent applications, plus 1 CIPO patent and 24 EPO patents, primarily in Corneal Treatments. Top assignees: Avedro, Inc., Identix Corporation, Lumerx, Inc.. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc David Friedman. Retrieved from https://idiyas.com/inventor/marc-david-friedman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 43 

% Patents Active = 79.1

 

 

Average Co-Inventor Count = 3.6

ph-index = 13

Forward Citations = 2,062(Granted Patents)


Location History:

  • Watertown, MA (US) (1991)
  • Needham Heights, MA (US) (2010 - 2013)
  • Needham, MA (US) (2005 - 2024)

Company Filing History:


Years Active: 1991-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cross-Linking
Cornea
Photosensitizer
Eye Treatments
Ocular Imaging
Biomechanical Properties
Drug Delivery
Phototherapy
Medical Devices
Therapy Systems
Biometric Systems
43 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Marc David Friedman

Introduction

Marc David Friedman, an accomplished inventor based in Needham, MA, holds an impressive portfolio of 34 patents. His work primarily focuses on advancements in ophthalmology, particularly systems and methods that enhance eye treatments and diagnostics. His inventions reflect a commitment to merging technology with healthcare to improve patient outcomes.

Latest Patents

Friedman's recent patents showcase his innovative approach towards enhancing ophthalmic treatments. One notable patent is for "Systems and methods for photoactivating a photosensitizer applied to an eye." This invention involves a wearable photoactivation device designed to provide antimicrobial treatment by directing photoactivating light to the eyes. The device is carefully engineered to ensure that it activates a photosensitizer applied to the eyes, thereby generating reactive oxygen species that can effectively combat infections, all while minimizing any biomechanical changes to the eye.

Another groundbreaking patent is titled "Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea." This patent outlines a corneal measurement system that utilizes an optical element to focus excitation light onto corneal tissue. The resulting fluorescence emission, generated by a fluorescing agent, is selectively transmitted through a pinhole structure to capture vital information regarding the cornea's characteristics at various depths. This system not only augments diagnostic capabilities but also enhances treatment planning for corneal conditions.

Career Highlights

Throughout his career, Marc David Friedman has played pivotal roles in several innovative companies. Notably, he has contributed to Avedro, Inc. and Identix Corporation, where he has likely influenced groundbreaking advancements in medical technologies. His extensive experience in these organizations highlights his expertise and dedication to the field of ophthalmology and related sciences.

Collaborations

Marc Friedman has collaborated with various esteemed professionals in his field, including David Muller and David Usher. These collaborations reflect his commitment to working alongside fellow innovators to drive advancements in medical technology, ensuring a versatile approach to problem-solving in the healthcare sector.

Conclusion

Marc David Friedman stands out as a leading inventor in the realm of ophthalmic innovations. His dedication to advancing medical technology through research and collaboration has not only resulted in numerous patents but has also significantly contributed to improving the quality of care for eye patients. With a continued focus on innovation, Friedman is sure to remain a prominent figure in the field of healthcare technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…